BP is Undervalued: Should You Bet on the Stock Right Away?

BP trades at 2.97x trailing EV/EBITDA, below the industry average of 5.88x and peers ExxonMobil at 9.40x and Chevron at 7.96x. WTI is around $90 per barrel, and BP’s Q2 2026 refining margins and oil trading improved while it processed approximately 1.5 million barrels per day; projects scheduled for 2028–2030 could also support future production and cash generation. BP gained 38.4% over the past year, trailing the industry’s 46.5%, and the article cites its Zacks Rank #1 (Strong Buy).

Analysis

The apparent valuation gap is a hypothesis, not a catalyst: a low trailing EV/EBITDA can reflect market skepticism about BP’s normalized cash generation, capital allocation, or balance-sheet trajectory rather than a mispricing. The key near-term driver is whether elevated crude prices convert into free cash flow after capex and shareholder distributions; geopolitical supply risk supports prices but also makes the earnings base unusually vulnerable to reversal. Refining and trading may cushion upstream volatility, but recent strong margins should not be annualized without evidence they persist.

The 2028–2030 projects are a distant option, not a near-term earnings re-rating trigger. Execution, startup timing, capex discipline, and incremental returns matter more than stated production growth. Relative underperformance could close if BP demonstrates durable cash returns and narrows any perceived execution or balance-sheet discount; otherwise the multiple gap versus ExxonMobil and Chevron may be justified. The article provides no leverage, normalized FCF, or project-return data, so the valuation case remains unverified. A sustained retreat in crude prices, weaker refining margins, project delays/cost overruns, or reduced distributions would falsify the bullish rerating thesis.

Key Decisions for Investors

• Consider a small, staged long BP position rather than chasing the headline valuation discount. Add only after checking latest net-debt trend, underlying free cash flow after capex, and buyback/dividend coverage; these are the missing tests of whether cheapness is investable.
• For a relative-value expression, pair a modest long BP with a smaller short XOM, sized to limit oil-beta exposure. The bet is on BP’s discount narrowing, not on XOM’s operating outlook; unwind if BP’s cash-return or leverage metrics deteriorate relative to XOM.
• Treat oil as the principal near-term risk: monitor the forward curve and realized prices, not just spot WTI. If prices sustain materially below the cited 2026 outlook, reduce exposure; higher spot prices alone are not confirmation of durable earnings.
• Keep the 2028–2030 project pipeline on a catalyst watchlist. Reassess on disclosed capex, startup schedules, and expected returns; delays or cost escalation weaken the long-duration value case before production is affected.